Some States Extend HETLIOZ Coverage to Patients With Non-24 Who Are Not Totally Blind
A patient filed a federal lawsuit challenging the unlawfulness of Colorado Medicaid's prior authorization criteria for HETLIOZ coverage.
A patient filed a federal lawsuit challenging the unlawfulness of Colorado Medicaid's prior authorization criteria for HETLIOZ coverage.
Vanda Pharmaceuticals Inc’s Marketing Authorization Application (MAA) for oral Hetlioz (tasimelteon) capsules has been accepted for evaluation by the European Medicines Agency (EMA) for the treatment of Non-24-Hour...